|By Business Wire||
|October 19, 2016 09:05 AM EDT|
Masimo (NASDAQ: MASI) announced today that it will release financial results for the third quarter ended October 1, 2016, after the market closes on Wednesday, November 2, 2016. The conference call to review the results will begin at 1:30 p.m. PT (4:30 p.m. ET) and will be hosted by Joe Kiani, Chairman and Chief Executive Officer, and Mark P. de Raad, Executive Vice President and Chief Financial Officer.
A live webcast of the conference call will be available online from the investor relations page of the company's corporate website at www.masimo.com. The dial-in numbers are (888) 520-7182 for domestic callers and +1 (706) 758-3929 for international callers. The reservation code for both dial-in numbers is 1397285. After the live webcast, the call will be available on Masimo's website through November 16, 2016. In addition, a telephonic replay of the call will be available through November 30, 2016. The replay dial-in numbers are (855) 859-2056 for domestic callers and +1 (404) 537-3406 for international callers. Please use reservation code 1397285.
Masimo (NASDAQ: MASI) is a global leader in innovative noninvasive monitoring technologies. Our mission is to improve patient outcomes and reduce the cost of care by taking noninvasive monitoring to new sites and applications. In 1995, the company debuted Masimo SET® Measure-through Motion and Low Perfusion™ pulse oximetry, which has been shown in multiple studies to significantly reduce false alarms and accurately monitor for true alarms. Masimo SET® is estimated to be used on more than 100 million patients in leading hospitals and other healthcare settings around the world. In 2005, Masimo introduced rainbow® Pulse CO-Oximetry technology, allowing noninvasive and continuous monitoring of blood constituents that previously could only be measured invasively, including total hemoglobin (SpHb®), oxygen content (SpOC™), carboxyhemoglobin (SpCO®), methemoglobin (SpMet®), and more recently, Pleth Variability Index (PVI®) and Oxygen Reserve Index (ORI™), in addition to SpO2, pulse rate, and perfusion index (PI). In 2014, Masimo introduced Root®, an intuitive patient monitoring and connectivity platform with the Masimo Open Connect (MOC-9™) interface. Masimo is also taking an active leadership role in mHealth with products such as the Radius-7™ wearable patient monitor and the MightySat™ fingertip pulse oximeter. Additional information about Masimo and its products may be found at www.masimo.com.
Masimo, SET, Signal Extraction Technology, Improving Patient Outcome and Reducing Cost of Care by Taking Noninvasive Monitoring to New Sites and Applications, rainbow, SpHb, SpOC, SpCO, SpMet, PVI are trademarks or registered trademarks of Masimo.
Feb. 19, 2017 10:30 PM EST Reads: 6,025
Feb. 19, 2017 09:30 PM EST Reads: 728
Feb. 19, 2017 08:00 PM EST Reads: 2,732
Feb. 19, 2017 06:45 PM EST Reads: 3,063
Feb. 19, 2017 06:15 PM EST Reads: 994
Feb. 19, 2017 06:00 PM EST Reads: 1,309
Feb. 19, 2017 05:45 PM EST Reads: 5,280
Feb. 19, 2017 05:45 PM EST Reads: 859
Feb. 19, 2017 05:00 PM EST Reads: 7,943
Feb. 19, 2017 05:00 PM EST Reads: 824
Feb. 19, 2017 05:00 PM EST Reads: 8,064
Feb. 19, 2017 05:00 PM EST Reads: 1,528
Feb. 19, 2017 04:15 PM EST Reads: 1,995
Feb. 19, 2017 03:45 PM EST Reads: 1,328
Feb. 19, 2017 02:45 PM EST Reads: 969